Main Metabolic Pathways of TAK-802, a Novel Drug Candidate for Voiding Dysfunction, in Humans: The Involvement of Carbonyl Reduction by 11β-hydroxysteroid Dehydrogenase 1

  • J. Takahashi, T. Kondo, K. Mouri, S. Asahi, M. Nishihara
  • Drug Research, December 2013, Thieme Publishing Group
  • DOI: 10.1055/s-0033-1363221

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1055/s-0033-1363221